New York, NY – Ipsos announced today the appointment of Marco DiBonaventura, Ph.D., as Senior Vice President and leader of the Global Evidence, Value, and Access (GEVA) group. In this position, he will oversee all operations of the group’s global activity including study design, implementation, data management, analysis, report writing, and scientific dissemination of health outcomes research and consulting engagements.
Prior to joining Ipsos, Dr. DiBonaventura spent eight years at Kantar Health as the Vice President of Health Outcomes within the Americas. He also worked at the Memorial Sloan-Kettering Cancer Center in the Department of Psychiatry and Behavioral Sciences. In addition to authoring over 100 publications, DiBonaventura has presented at numerous conferences, serves on the editorial board for a number of leading journals, and is on several industry advisory boards. He received his Ph.D. and M.S. in Social/Health Psychology from Rutgers University.
Richard W. Martin has also joined Ipsos Healthcare as Senior Vice President, North America. Mr. Martin will serve as the Global Account Director for one of the division’s key clients. He brings a wealth of experience in life sciences, having advised and consulted with the pharmaceutical and biotech segments for more than two decades. Prior to his consulting career, Mr. Martin worked in sales, brand, and marketing management in the pharmaceutical and diagnostics industries.
Elizabeth Machado has joined Ipsos Healthcare as Vice President, North America, where she will work with key clients as a collaborator and leader on a range of pressing commercial issues. She will also help to enhance Ipsos Healthcare’s therapeutic Center of Excellence (CoE) strategy in major disease states. Over the last 14 years, Machado has held numerous positions within PSL Group -- most recently, as a Senior Vice President with Instar. She also spent several years working for non-profit organizations, including the United Nations and NYU Medical Center.
Announcing the appointments, Steve Girling, President, North America, Ipsos Healthcare said: “We’re constantly looking for the best leaders and teams in the industry to support our phenomenal clients. In Marco, Richard, and Elizabeth we have appointed three very senior, proven, and already trusted partners to our biopharma partners. All three will play a major role in leading our business through the next few chapters of innovation and growth at Ipsos Healthcare.”
For more information on this news release, please contact:
Director, Marketing Services, North America
Ipsos ranks third in the global research industry. With a strong presence in 87 countries, Ipsos employs more than 16,000 people and has the ability to conduct research programs in more than 100 countries. Founded in France in 1975, Ipsos is controlled and managed by research professionals. They have built a solid Group around a multi-specialist positioning—Media and advertising research; Marketing research; Client and employee relationship management; Opinion & social research; Mobile, Online, Offline data collection and delivery. Ipsos has been listed on the Paris Stock Exchange since 1999. www.ipsos.com